期刊文献+

结核分枝杆菌RelE毒素蛋白对肺癌A-549细胞成瘤性的抑制作用 被引量:1

RelE toxin protein of Mycobacterium Tuberculosis reduces tumorigenicity of lung cancer A-549 cell
在线阅读 下载PDF
导出
摘要 目的探索结核分枝杆菌RelE毒素蛋白对动物体内的肺癌A-549细胞的成瘤性的影响,以及因此产生的对动物免疫功能的作用。方法构建BALB/C小鼠的免疫抑制模型,通过接种稳定表达结核分枝杆菌RelE毒素蛋白、RelB抗毒素蛋白和RelBE毒素-抗毒素蛋白的肺癌A-549细胞株,含空质粒PcDNA3.1(+)的A-549细胞株,以及正常的肺癌A-549细胞,构建BALB/C小鼠荷瘤模型,观察各组小鼠的肿瘤生长情况,并测定各组小鼠的脾淋巴细胞增殖活性以及血清IFN-γ和IL-2的浓度。结果接种了表达RelE毒素蛋白的A-549细胞的小鼠组,肿瘤生长较其它实验组慢,肿瘤结节的瘤体体积和数量都较其它实验组有明显差异(P<0.05)。对各组小鼠免疫功能变化的研究发现,各实验组小鼠的脾淋巴细胞增殖活性以及血清IFN-γ和IL-2的浓度的差异没有统计学意义(P>0.05)。结论结核分枝杆菌RelE毒素蛋白对肺癌A-549细胞的成瘤性有抑制作用。 Objective To investigate the effect of RelE toxin protein of Mycobacterium Tuberculosis on lung cancer A-549 cell.Methods The immunosuppression BALB/C mice were induced by intraperitoneal injection of CP.The mice were divided into five groups and seeded with the A-549 cells,A-549 cells that stable express RelE toxin protein,RelB antitoxin protein,RelBE toxin-antitoxin protein of mycobacterium tuberculosis and the A-549 cells contained empty vector PcDNA3.1(+).The tumor growth,spleen lymphocyte proliferation and serum IFN-γ and IL-2 were observed.Result The tumor growth of the mice seeded with A-549 cells contained RelE toxin protein was slower than that of the other groups.The number of tumor nodus of the mice seeded with A-549 cells contained RelE toxin protein was less than that of the other groups.Conclusion RelE toxin protein of mycobacterium tuberculosis has tumorigenicity inhibition to lung cancer A-549 cell.
出处 《西部医学》 2010年第11期1988-1991,共4页 Medical Journal of West China
基金 教育部重点项目(No.104152) 四川省科技重点项目(03SG022-009)资助
关键词 结核分枝杆菌 RelE 成瘤性 Mycobacterium tuberculosis RelE Tumorigenicity
  • 相关文献

参考文献10

二级参考文献32

  • 1樊永平,聂惠民,周勇,严宣左,王庆国,傅延龄,陶君悌,张庆.健脾金丹对正常小鼠及环磷酰胺所致免疫受抑小鼠免疫功能的增强作用[J].中国中西医结合杂志,1993,13(4):223-225. 被引量:10
  • 2张永恒,李凤云,吴玉波,于桂兰.颐康冲剂对顺铂、喜树碱、环磷酰胺的增效作用及其对毒性影响的实验研究[J].中国药房,1996,7(3):112-113. 被引量:1
  • 3黄晋生,刘朝阳,张书元,贵友章,傅乃武.中药白龙冲剂和环磷酰胺对小鼠免疫功能的影响[J].肿瘤防治研究,1996,23(5):270-272. 被引量:8
  • 4李振.恶性肿瘤的化学治疗与免疫治疗[M].北京:人民卫生出版社,1998.44-46.
  • 5Poulter LW,Turk JL.Proportional increase in the θ carrying lymphocyte in peripheral lymphoid tissue following treatment with cyclophosphamide[ J ].Nature New Biol, 1972,238:17.
  • 6Turk JL, Parken D. Effect of cyclophosphamide on immunological control mechanisms[J]. Immunological Rev, 1982,65:99-113.
  • 7McMichael A J, Fabre JW. Monoclonal antibodies in clinical medicine[ M ].London: Academic Press INC Ltd, 1982.230.
  • 8Lawomir WP. Reversal of tumor-induced immunosuppression: A new approach to cancer therapy[J] .Ann Immunother, 1997,20(3): 165-177.
  • 9Lagrange PH, Mackaness GB, Miller TE. Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide[J] .J Exp Med, 1974,139:1529-1539.
  • 10Winkelstein A, Mikulla JM, Nankin HR, et al. Mechanisms of immunosuppression:Effects of cyclophosphamide on lymphocytes[J]. Lab Clin Med,1972,80:.506-513.

共引文献175

同被引文献41

  • 1Schuster CF, Bertram R. Toxin-antitoxin systems are ubiquitous and versatile modulators of prokaryotic cell fate. FEMS Microbiol Lett, 2013, 340(2) : 73-85.
  • 2Sberro H, Leavitt A, Kiro R, et al. Discovery of functional toxin/ antitoxin systems in bacteria by shotgun cloning. Mol Cell, 2013, 50(1) : 136-148.
  • 3Nolle N, Schuster CF, Bertram R. Two paralogous yefM-yoeB lo- ci from Staphylococcus equorum encode functional toxin-antitoxin systems. Microbiology.
  • 4Fineran PC, Blower TR, Foulds IJ, et al. The phage abortive in- fection system, ToxiN, functions as a pmtein-RNA toxin-antitoxin pair. Proc Natl Acad Sci USA, 2009, 106(3) : 894-899.
  • 5Brantl S. Bacterial type I toxin-antitoxin systems. RNA Biol, 2012, 9(12) : 1488-1490.
  • 6Van Melderen L, Saavedra De Bast M. Bacterial toxin-antitoxin systems: more than selfish entities?. PLoS Genet, 2009, 5 (3) : e1000437.
  • 7Cook GM, Robson JR, Frampton RA, et al. Ribonucleases in bacterial toxin-antitoxin systems. Biochim Biophys Acta, 2013, 1829(6-7) : 523-531.
  • 8Smith AB, L6pez-Villarejo J, Diago-Navarro E, et al. A common origin for the bacterial toxin-antitoxin systems pard and ccd, sug- gested by analyses of toxin/target and toxin/antitoxin interactions. PLoS One, 2012, 7(9) : e46499.
  • 9Liu M, Zhang Y, Inouye M, et al. Bacterial addiction module toxin Doc inhibits translation elongation through its association with the 30 S ribosomal subunit. Proc Natl Acad Sci USA, 2008, 105(15) : 5885-5890.
  • 10Hansen S, Vulic M, Min J, et al. Regulation of the Escherichia coli HipBA toxin-antitoxin system by proteolysis. PLoS One, 2012, 7(6) : e39185.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部